SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-021673
Filing Date
2023-04-28
Accepted
2023-04-28 16:55:58
Documents
7
Period of Report
2023-06-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20007004x2_def14a.htm DEF 14A 1140916
2 logo_aquestive-reg.jpg GRAPHIC 54294
3 logo_aquestive-regx1.jpg GRAPHIC 43389
4 ny20007004x2_pc01.jpg GRAPHIC 620354
5 ny20007004x2_pc02.jpg GRAPHIC 577831
6 sig_danielbarber.jpg GRAPHIC 15636
7 sig_lorijbraender.jpg GRAPHIC 26060
  Complete submission text file 0001140361-23-021673.txt   2983009
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38599 | Film No.: 23867762
SIC: 2834 Pharmaceutical Preparations